In our study, we report that NSCLC CSCs co-expressing CXCR4 and CD73 are enriched in lymph node metastasis compared to primary tumors, indicating that the cells able to initiate metastasis may have an enhanced immunosuppressive activity. The gene discussed is CXCR4; the disease is non-small cell lung carcinoma.